4th EUROFORUM-Conference Business for BioTech
15 September 2003 - 16 September 2003
Austria
The biotechnology sector is considered to have a very big growth potential in the near future. As well as other sectors the German biotech sector suffers from the difficult business environment. As a consequence there are more insolvencies, mergers and take-overs. The world-wide tendency is a consolidation of the market. In order to secure the existence of biotech companies, new strategies have to be developed and realized.
Top-class speakers from biotech companies, VC-companies, universities and consulting companies will provide you with information about possible solutions and new strategies at this conference.
There will be two parallel interactive workshops in the afternoon of the first day, where the delegates work on the topics M&A or outsourcing. The delegates will get an overview of these topics during the lectures held in the morning. Experienced executives of a biotech company will coach both workshops.
Further information and contact http://www.vc-pe.de(öffnet in neuem Fenster) Linda Kliem, Tel. 0049-211-9686-3532.
,
Top-class speakers from biotech companies, VC-companies, universities and consulting companies will provide you with information about possible solutions and new strategies at this conference.
There will be two parallel interactive workshops in the afternoon of the first day, where the delegates work on the topics M&A or outsourcing. The delegates will get an overview of these topics during the lectures held in the morning. Experienced executives of a biotech company will coach both workshops.
Further information and contact http://www.vc-pe.de(öffnet in neuem Fenster) Linda Kliem, Tel. 0049-211-9686-3532.
,